Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global vacant gelatin capsules market was valued at USD 2.4 billion in 2024. The market is projected to grow from USD 2.55 billion in 2025 to USD 3.85 billion by 2032, exhibiting a CAGR of 5.3% during the forecast period. This growth trajectory is supported by the expanding global pharmaceutical market, which was valued at USD 1.475 trillion in 2022 and is growing at a steady CAGR of 5%.
Vacant gelatin capsules are pharmaceutical-grade shells manufactured from gelatin, a natural polymer derived from animal collagen. These empty shells are designed to be filled with powdered or liquid medications, nutraceuticals, or supplements. They are available in two primary types: gastric soluble capsules, which dissolve in the stomach, and enteric capsules, which are designed to resist stomach acid and dissolve in the intestinal tract. Their primary function is to provide a tasteless, odorless, and easy-to-swallow dosage form that improves patient compliance.
The market is experiencing steady growth due to several key drivers, including the rising global demand for pharmaceutical products and the increasing popularity of nutraceuticals and vitamins. Furthermore, advancements in capsule manufacturing technologies that allow for specialized release profiles, such as delayed or sustained release, are contributing to market expansion. However, the industry also faces challenges, such as volatility in the price and supply of raw gelatin and increasing competition from vegetarian alternatives like HPMC capsules. Key players like Lonza Capsules & Health Ingredients and ACG (Associated Capsule Group) continue to drive innovation and capacity expansion to meet the growing demand across various therapeutic and supplement applications.
Rising Pharmaceutical and Nutraceutical Demand
The global vacant gelatin capsules market is primarily driven by the expanding pharmaceutical and nutraceutical industries. The increasing prevalence of chronic diseases and a growing consumer focus on preventive healthcare are fueling the demand for encapsulated drugs and dietary supplements. Gelatin capsules remain a preferred delivery system due to their excellent bioavailability, ease of swallowing, and efficient masking of unpleasant tastes and odors.
Advantages Over Alternative Delivery Forms
Vacant gelatin capsules offer significant advantages, including precise dosage, product stability, and improved shelf life compared to liquid or powder forms. Their rapid dissolution in the stomach ensures quick release of active ingredients, which is a critical factor for many pharmaceutical applications. This reliability makes them a standard choice for a wide range of formulations.
➤ The nutraceutical sector alone is projected to account for over 40% of the demand for empty gelatin capsules, driven by the booming market for vitamins, minerals, and herbal supplements.
Furthermore, technological advancements in capsule manufacturing, such as the development of specialized grades for enteric and delayed-release applications, are creating new avenues for market growth and meeting more sophisticated therapeutic needs.
MARKET CHALLENGES
Competition from Non-Animal and Alternative Materials
A significant challenge for the vacant gelatin capsules market is the growing consumer preference for vegetarian and vegan products. This has led to increased competition from plant-based capsules, such as those made from hydroxypropyl methylcellulose (HPMC). Manufacturers of gelatin capsules must address this shift by emphasizing the proven safety, superior dissolution profile, and cost-effectiveness of bovine- or porcine-derived gelatin.
Other Challenges
Supply Chain and Raw Material Volatility
The market is susceptible to fluctuations in the price and availability of raw materials, primarily gelatin derived from animal bones and hides. Outbreaks of animal diseases can disrupt supply chains and lead to price instability, posing a consistent challenge for manufacturers.
Stringent Regulatory Hurdles
Compliance with rigorous quality standards and pharmaceutical regulations across different regions adds complexity and cost to the manufacturing process. Ensuring consistent quality and meeting pharmacopeial specifications for dissolution and stability is a continuous operational challenge.
Cultural and Religious Sensitivities
The animal origin of traditional gelatin capsules acts as a major market restraint. In regions with large Hindu, Muslim, or Jewish populations, or among consumers adhering to vegetarian or vegan lifestyles, there is a clear avoidance of gelatin-based products. This limits the potential consumer base and compels pharmaceutical companies to offer alternative shell options for certain markets, thereby restraining the growth of the standard gelatin capsule segment.
Moisture Sensitivity and Storage Limitations
Gelatin capsules are hygroscopic and can become brittle in low humidity or soft and sticky in high humidity, which can affect their mechanical integrity and shelf life. This inherent sensitivity requires controlled storage and packaging conditions, adding to logistical costs and complexity, which can be a restraining factor, especially in developing regions with extreme climatic variations.
Expansion in Emerging Economies
Significant opportunities exist in the rapidly growing pharmaceutical markets of Asia-Pacific, Latin America, and Africa. Improving healthcare infrastructure, rising disposable incomes, and increasing government focus on generic drug production in these regions are expected to drive substantial demand for vacant gelatin capsules. Local manufacturing partnerships and capacity expansion in these areas present a key growth strategy.
Innovation in Functional Capsules
The development of advanced gelatin capsules with enhanced functionalities represents a major opportunity. This includes capsules tailored for targeted drug delivery, improved bioavailability of poorly soluble drugs, and capsules with built-in tracking technologies for supply chain integrity. Investing in R&D to create high-value, differentiated products can allow manufacturers to capture premium market segments and reduce price-based competition.
Contract Manufacturing and Customization
The trend towards outsourcing by pharmaceutical companies offers robust growth opportunities for contract manufacturers specializing in capsule filling. Providing customized solutions, including a wide range of sizes, colors, and printing capabilities for brand differentiation, can be a significant competitive advantage and a source of stable revenue.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Gastric Soluble capsules represent the dominant product form, widely preferred for their rapid disintegration in the stomach, making them ideal for a broad spectrum of active pharmaceutical ingredients. Their straightforward manufacturing process and excellent patient compliance due to ease of swallowing contribute to their leadership. The Enteric segment, while significant, is driven by the specialized need to protect drugs from stomach acid or to facilitate targeted release in the intestines, finding strong application in drug formulations requiring delayed or sustained release mechanisms. |
| By Application |
|
Pharmacy applications hold a commanding position as the primary channel for dispensing prescription and over-the-counter medications to the general public. This segment benefits from the vast distribution network of retail and chain pharmacies globally. The Hospital segment is also a major consumer, utilizing capsules for in-patient treatments and formulary medications. Clinics and other settings, including research and compounding pharmacies, represent important niche markets where capsules are employed for specialized therapeutic regimens and clinical trials. |
| By End User |
|
Pharmaceutical Companies are the principal end users, driving market demand through the extensive use of vacant gelatin capsules for both chemical and biologic drug formulations. Their demand is fueled by continuous drug development, lifecycle management of existing products, and the need for reliable, patient-friendly dosage forms. Nutraceutical Companies are a rapidly growing segment, leveraging capsules for dietary supplements and vitamins. Contract Manufacturing Organizations represent a critical segment, as they provide formulation and manufacturing services to companies that lack in-house capsule filling capabilities, adding a layer of flexibility and scalability to the supply chain. |
| By Drug Formulation |
|
Chemical Drugs constitute the most substantial demand segment for vacant gelatin capsules, given the vast number of small molecule therapeutics that are ideally suited for this delivery system. The established manufacturing processes and compatibility with a wide array of APIs solidify its leading role. The burgeoning Biologic Drugs segment presents unique opportunities and challenges, with capsules being explored for certain biologics that are stable in solid oral dosage forms. The Nutraceuticals segment demonstrates robust growth, driven by increasing consumer health consciousness and the preference for encapsulated vitamins and herbal supplements. |
| By Capsule Size |
|
Size 0 capsules are typically the most widely used, offering an optimal balance between fill capacity and patient swallowability for a majority of standard drug formulations. The slightly larger Size 00 is crucial for high-dose medications or combination therapies requiring greater payload capacity. Smaller sizes, such as Size 1 and below, are essential for low-dose, potent drugs, pediatric formulations, and applications where minimizing excipient intake is a priority, catering to specific therapeutic and demographic needs with precision. |
A Market Dominated by Global Specialists and Cost-Competitive Regional Manufacturers
The global vacant gelatin capsules market features a competitive structure led by a few major multinational players with extensive manufacturing capabilities and global supply chains. Lonza Capsules & Health Ingredients stands as a dominant force, leveraging its strong reputation for quality and innovation in pharmaceutical ingredients to command a significant market share. These leading companies compete on factors such as product quality, consistent supply, technological advancements in capsule manufacturing (including plant-based alternatives), and compliance with stringent international regulatory standards. The market is characterized by long-standing relationships with large pharmaceutical companies, making it challenging for new entrants to gain significant traction without substantial investment and proven reliability.
Beyond the top-tier players, the market includes a substantial number of specialized and regional manufacturers that cater to specific geographic markets or niche applications. Companies in Asia, particularly in China and India, have grown substantially by offering cost-competitive products. Firms like Xinchang County No.6 Capsule Factory, Zhejiang Laerui Biological Technology Co., Ltd., and Nectar Lifesciences Ltd. have established strong positions, often focusing on supplying the vast domestic and regional generics market. These players compete primarily on price, flexibility, and the ability to serve smaller-scale or more specialized orders, creating a dynamic and fragmented competitive environment alongside the global leaders.
List of Key Vacant Gelatin Capsules Companies ProfiledLonza Capsules & Health Ingredients
Shanxi Delta Biotech Co., Ltd.
BioCaps Enterprise
Xiamen Gelken Gelatin Co., Ltd.
Nectar Lifesciences Ltd. (NLL)
Healthcaps India
Yasin Capsule
Erawat Pharma
ACG Associated Capsules
Qualicaps
Bright Pharmacaps Inc.
The global Vacant Gelatin Capsules market is experiencing significant growth, directly linked to the expansion of the pharmaceutical industry. The overall pharmaceutical market, valued at 1475 billion USD in 2022, is growing at a CAGR of 5%. This growth is fueled by increasing global demand for healthcare, technological advancements, and the rising prevalence of chronic diseases. As a critical component for both chemical and biological drug delivery, the demand for vacant gelatin capsules is propelled by this broad industry momentum. The capsules are essential for encapsulating powdered or liquid active ingredients, making them a staple in drug manufacturing.
Other TrendsSegmentation by Type and Release Mechanism
The market is distinctly segmented by capsule type. Gastric soluble capsules, designed to dissolve in the stomach's acidic environment, and enteric capsules, which are formulated to resist stomach acid and dissolve in the intestines, cater to different therapeutic needs. This segmentation allows pharmaceutical companies to select the appropriate delivery system based on drug stability and targeted release profiles, enhancing treatment efficacy.
Application Across Healthcare Settings
Vacant gelatin capsules are utilized across various healthcare channels, including pharmacies, hospitals, and clinics. Their widespread use ensures a consistent and broad-based demand. The convenience, dosage accuracy, and patient compliance offered by capsules make them a preferred choice for medication administration in both prescription and over-the-counter drugs.
Regional Market Diversification and Competitive LandscapeGeographically, the market spans North America, Europe, Asia, South America, and the Middle East & Africa, with Asia presenting significant growth potential due to expanding healthcare infrastructure. The competitive landscape includes key players such as Lonza Capsules & Health Ingredients and Nectar Lifesciences Ltd., who drive innovation and market expansion. The industry navigates challenges like stringent regulatory requirements and the need for continuous R&D investment to maintain product quality and compliance amidst evolving global health needs, as underscored by recent supply chain management priorities highlighted during the COVID-19 pandemic.
Regional Analysis: Vacant Gelatin Capsules MarketNorth America
North America represents a mature yet highly significant market for vacant gelatin capsules, characterized by stringent regulatory standards and a strong preference for premium, high-quality pharmaceutical products. The market is driven by a sophisticated pharmaceutical industry that invests heavily in research and development for novel drug formulations, many of which utilize capsule delivery systems. The region has a well-established nutraceutical sector, with consumers showing high demand for encapsulated vitamins and specialty supplements. A key dynamic is the shift towards vegetarian and halal-certified capsules, prompting manufacturers to adapt their offerings. The presence of major global capsule manufacturers ensures a stable supply, but competition is intense, focusing on product differentiation, technological innovation in capsule design, and compliance with rigorous Good Manufacturing Practices (GMP).
Europe
The European market for vacant gelatin capsules is defined by its robust regulatory framework and a strong emphasis on product safety and quality. The region has a large and advanced pharmaceutical industry that demands consistent, high-grade capsules for both prescription and over-the-counter medicines. Similar to North America, there is a notable and growing consumer trend towards non-animal-derived capsules, such as those made from HPMC (hydroxypropyl methylcellulose), driven by dietary preferences and sustainability concerns. This has led to a diversified product portfolio from suppliers. The market is also supported by a significant nutraceutical industry and an aging population that consumes a high volume of pharmaceutical products, ensuring steady demand. Market players compete on the basis of compliance, technical support, and the ability to provide specialized capsule solutions.
South America
The South American market for vacant gelatin capsules is experiencing steady growth, fueled by economic development and improving healthcare access. Brazil and Argentina are the key markets within the region, with growing local pharmaceutical production capabilities. The demand is primarily driven by the increasing production of generic drugs, which are more affordable and widely consumed. However, the market faces challenges related to economic volatility and infrastructural limitations in some areas, which can impact the consistency of supply chains. The nutraceutical sector is also emerging as a growth area, though it is not as developed as in other regions. Market dynamics are influenced by price sensitivity, making cost-competitive imports from Asia-Pacific particularly influential in the region.
Middle East & Africa
The Middle East and Africa region presents a market with high growth potential but is currently characterized by fragmentation and varying levels of development. The Gulf Cooperation Council (GCC) countries represent the most advanced sub-market, with high healthcare expenditure, modern infrastructure, and a reliance on imported pharmaceutical products, including capsules. In contrast, many African nations have nascent local manufacturing sectors and depend heavily on imports and international aid for pharmaceutical supplies. The overall market growth is propelled by increasing government investment in healthcare, a rising burden of chronic diseases, and growing population. A key trend is the demand for halal-certified capsules in Muslim-majority countries, creating a specific niche for compliant manufacturers. The market's evolution is closely tied to economic stability and healthcare infrastructure development.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global vacant gelatin capsules market was valued at USD 2.4 billion in 2024 and is projected to reach USD 3.85 billion by 2032.
Which key companies operate in Global Vacant Gelatin Capsules Market?
-> Key players include Lonza Capsules & Health Ingredients, ACG (Associated Capsule Group), Nectar Lifesciences Ltd. (NLL), and others.
-> Key growth drivers include expanding pharmaceutical market, rising demand for nutraceuticals, and technological advancements.
-> Asia-Pacific shows significant growth, while North America and Europe remain key markets.
-> Emerging trends include vegetarian alternatives like HPMC capsules and advancements in manufacturing technologies.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates